BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  PATH EX, Inc. Announces Successful $5 Million Financing Round to Advance CycloPE(R), a Breakthrough Treatment for Sepsis

  May 9, 2025

   · 

  2 min read
• Press Releases

  Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment

  May 9, 2025

   · 

  15 min read
• Press Releases

  ITULATEK® approved for treatment of children and adolescents in Canada

  May 9, 2025

   · 

  2 min read
• Press Releases

  Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

  May 9, 2025

   · 

  9 min read
• Press Releases

  Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025

  May 9, 2025

   · 

  4 min read
• Press Releases

  Relay Therapeutics to Participate in Two Upcoming Investor Conferences

  May 9, 2025

   · 

  1 min read
• Press Releases

  Alligator Bioscience Completes Phase 3 GMP Manufacturing of Mitazalimab, Remains on Track for Trial Initiation with Partner

  May 9, 2025

   · 

  1 min read
• Press Releases

  Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

  May 9, 2025

   · 

  15 min read
• Press Releases

  Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study

  May 9, 2025

   · 

  9 min read
• Press Releases

  Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

  May 9, 2025

   · 

  1 min read